ARC Logo
  • About
  • Workshops
  • Resource Hub
  • News & Blog
  • Request Support
  • Contact
  • MORE
    • Disclaimer
    • Interactive Dosimetry Explorer
  • Appalachian Radiotheranostic Coalition (ARC)
  • Workshops
  • News & Blog
  • Request Support
    • Appalachian Radiotheranostic Coalition (ARC)
  • About
  • Contact

Dustin Osborne, PhD, DABSNM, DABR

865-305-8264

dosborne@utmck.edu

The ARChives

News & Blog

Two New Approvals, One Big Week for Theranostics

By Dustin Osborne • September 18, 2026

What We Mean When We Say “Dose”: Units, BED, EQD2, and a Calculator You Can Use

By Dustin Osborne • September 5, 2026

NRC 8.39 Rev 2: Proposed Changes and What you Need to Know

By Dustin Osborne • August 14, 2026
Abstract dark-blue tech interface with orbiting dots and a small login panel on the right.

PSMA Therapy at Diagnosis: What Pluvicto's New Approval Means for the Corridor

By Dustin Osborne • August 7, 2026

What I told Administrators at AHRA 2026

By Dustin Osborne • July 17, 2026

We Hold These Thresholds to Be Self-Evident: What the NRC's Proposed Rule Changes for Patient Release

By Dustin Osborne • July 2, 2026

Two Meetings, One Message: SNMMI + ASCO

By Dustin Osborne • June 13, 2026

Why SNMMI Matters Even if you Aren't Attending

By Dustin Osborne • May 30, 2026
SNMMI 2026: Los Angeles

2nd ARC Workshop: Roanoke and the Future of Theranostics

By Dustin Osborne • May 22, 2026

What is Dosimetry? And Why Does it Matter for Patients in Appalachia?

By Dustin Osborne • May 8, 2026
Show More

Tell us how we can help you.

Get In Touch
ARC logo
  • About
  • Workshops
  • Resource Hub
  • News & Blog
  • Request Support
  • Contact
  • Disclaimer
  • Interactive Dosimetry Explorer